SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

Email this article to a friend

Ayad M Al-Katib^*, Yuan Sun, Anton S Goustin, Asfar S Azmi, Ben Chen, Amro Aboukameel and Ramzi M Mohammad

Journal of Hematology & Oncology 2009, 2:8 doi:10.1186/1756-8722-2-8